Blood cancers, Cell type, Low grade lymphoma, Lymphoma, Non-Hodgkin lymphoma (NHL)
Results
Phase 2
This trial looked at quisinostat for cutaneous T cell lymphoma that had come back or got worse after other treatment.
The trial was open for people to join between 2011 and 2012. The team published the results in 2016.
Recruitment start: 1 November 2011
Recruitment end: 23 April 2012
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Professor Sean Whittaker
Experimental Cancer Medicine Centre (ECMC)
Janssen-Cilag
Last reviewed: 06 Jul 2023
CRUK internal database number: 9379
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
